PR Newswire Clinical TrialsOriginal article
Continuous Glucose Monitors Help Type 2 Diabetes Patients Spend Five More Hours a Day in Healthy Blood Sugar Range
Data ReadoutpositiveContinuous Glucose MonitorPositive
AI Analysis
Summary
A large-scale clinical trial demonstrates that continuous glucose monitors significantly improve blood sugar control in type 2 diabetes patients not using insulin, with patients spending five additional hours per day in healthy blood sugar ranges. This provides strong evidence for CGM efficacy in non-insulin-dependent diabetes management.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Large scale clinical trial demonstrates CGMs significantly improve blood sugar control in type 2 diabetes patients not using insulin, with patients spending five more hours per day in healthy blood sugar range
Importance:6/10
Sentiment:
0.70
diabetescontinuous glucose monitoringCGMtype 2 diabetesclinical trialblood sugar controlnon-insulin
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on October 14, 2026 10:03 PM